Evidence map›Paper›PMID 36982620›Full record

ArticleInternational journal of molecular sciences2023

The

Abdelghani Zekhnini, Marcel Albacar, Antonio Casamayor, Joaquín Ariño

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CRISPR-based synthetic biology toolkit development inSynthetic and systems biotechnology · 2026
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Abdelghani ZekhniniInstitut de Biotecnologia i Biomedicina, Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.ORCID 0000-0002-4265-8447
Marcel AlbacarInstitut de Biotecnologia i Biomedicina, Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.ORCID 0000-0002-2612-2888
Antonio CasamayorInstitut de Biotecnologia i Biomedicina, Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.ORCID 0000-0003-2788-7329
Joaquín AriñoInstitut de Biotecnologia i Biomedicina, Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.ORCID 0000-0002-6774-2987
Universitat Autònoma de Barcelona · ES

Funding

Ministerio de Ciencia e Innovación (Spain) PID2020-113319RB-I00
6 · The paper itself

Abstract

The

Indexed as

Saccharomyces cerevisiae ProteinsTranscription FactorsAdenosine TriphosphatasesAmino AcidsDNA-Binding ProteinsGene Expression Regulation, FungalNuclear ProteinsRNA-Binding ProteinsSaccharomyces cerevisiaeSodium-Potassium-Exchanging ATPaseAdenosine TriphosphatasesAmino AcidsCRZ1 protein, S cerevisiaeDNA-Binding ProteinsENA1 protein, S cerevisiaeNuclear ProteinsRNA-Binding ProteinsSaccharomyces cerevisiae ProteinsSodium-Potassium-Exchanging ATPaseSTP1 protein, S cerevisiaeStp2 protein, S cerevisiaeTranscription Factorsenvironmental alkalinizationSaccharomyces cerevisiaestress responsetranscriptional regulation

Identifiers

PMID36982620
PMCPMC10055992
OpenAlexW4324151671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.